Silencing of the P2X7 receptor enhances amyloid-β phagocytosis by microglia

Biochemical and Biophysical Research Communications

Volumn 434, Issue 2, 2013, Pages 363-369

  Ni, Jiong ^a   Wang, Peijun ^a   Zhang, Jingfa ^a   Chen, Wei ^a   Gu, Limin ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Alzheimer's disease; Amyloid peptides; Microglia; P2X7 receptor; RNA interference

Indexed keywords

AMYLOID BETA PROTEIN; CYCLOOXYGENASE 2; INTERLEUKIN 1BETA; PURINERGIC P2X7 RECEPTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME INHIBITION; GENE SILENCING; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; MICROGLIA; MOUSE; NEUROPROTECTION; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE;

AMYLOID BETA-PEPTIDES; ANIMALS; CELLS, CULTURED; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; GENE SILENCING; IMMUNOHISTOCHEMISTRY; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; ISOXAZOLES; MEMBRANE PROTEINS; MICE; MICE, INBRED ICR; MICROGLIA; PEPTIDE FRAGMENTS; PHAGOCYTOSIS; PRIMARY CELL CULTURE; PURINERGIC P2X RECEPTOR ANTAGONISTS; RECEPTORS, PURINERGIC P2X7; RNA INTERFERENCE; RNA, SMALL INTERFERING; ROSANILINE DYES; SULFONES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84877061566     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.03.079     Document Type: Article

References (29)

1. Akiyama H., Arai T., Kondo H., et al. Cell mediators of inflammation in the Alzheimer disease brain. Alzheimer Dis. Assoc. Disord. 2000, 14:S47-S53.
2. Streit W.J. Microglia as neuroprotective, immunocompetent cells of the CNS. Glia 2002, 40:133-139.
3. Sanz J.M., Chiozzi P., Ferrari D., et al. Activation of microglia by amyloid-β requires P2X7 receptor expression. J. Immunol. 2009, 182:4378-4385.
4. Takata K., Kitamura Y., Yanagisawa D., et al. Microglial transplantation increases amyloid-β clearance in Alzheimer model rats. FEBS Lett. 2007, 581:475-478.
5. Rogers J., Strohmeyer R., Kovelowski C.J., et al. Microglia and inflammatory mechanisms in the clearance of amyloid-β peptide. Glia 2002, 40:260-269.
6. Mandrekar-Colucci S., Landreth G.E. Microglia and inflammation in Alzheimer's disease. CNS Neurol. Disord. Drug Targets 2010, 9:156-167.
7. Meda L., Cassatella M.A., Szendrei G.I., et al. Activation of microglial cells by amyloid-β protein and interferon-β. Nature 1995, 374:647-650.
8. Heneka M.T., O'Banion M.K. Inflammatory processes in Alzheimer's disease. J. Neuroimmunol. 2007, 184:69-91.
9. Song M., Xiong J.X., Wang Y.Y., et al. VIP enhances phagocytosis of fibrillar amyloid-β by microglia and attenuates amyloid deposition in the brain of APP/PS1 mice. PLoS One 2012, 7:e29790.
10. Monsonego A., Weiner H.L. Immunotherapeutic approaches to Alzheimer' s disease. Science 2003, 302:834-838.
11. North R.A. Molecular physiology of P2X receptors. Physiol. Rev. 2002, 82:1013-1067.
12. Monif M., Reid C.A., Powell K.L., et al. The P2X7 receptor drives microglial activation and proliferation: a trophic role for the P2X7R pore. J. Neurosci. 2009, 29:3781-3791.
13. Parvathenani L.K., Tertyshnikova S., Greco C.R., et al. P2X7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer's disease. J. Biol. Chem. 2003, 278:13309-13317.
14. McLarnon J.G., Ryu J.K., Walker D.G., et al. Upregulated expression of purinergic P2X7 receptor in Alzheimer disease and amyloid-β peptide-treated microglia and in peptide-injected rat hippocampus. J. Neuropathol. Exp. Neurol. 2006, 65:1090-1097.
15. Ryu J.K., McLarnon J.G. Block of purinergic P2X7 receptor is neuroprotective in an animal model of Alzheimer's disease. Neuroreport 2008, 19:1715-1719.
16. Takenouchi T., Sekiyama K., Sekigawa A., et al. P2X7 receptor signaling pathway as a therapeutic target for neurodegenerative diseases. Arch. Immunol. Ther. Exp. 2010, 58:91-96.
17. Gonzalez-Alegre P. Therapeutic RNA interference for neurodegenerative diseases: from promise to progress. Pharmacol. Ther. 2007, 114:34-55.
18. Song B., Davis K., Liu X.S., et al. Inhibition of Polo-like kinase 1 reduces amyloid-β-induced neuronal cell death in Alzheimer's disease. Aging (Albany NY) 2011, 3:846-851.
19. Singer O., Marr R.A., Rockenstein E., et al. Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model. Nat. Neurosci. 2005, 8:1343-1349.
20. Friedle S.A., Brautigam V.M., Nikodemova M., et al. The P2X7-egr pathway regulates nucleotide-dependent inflammatory gene expression in microglia. Glia 2011, 59:1-13.
21. Koenigsknecht-Talboo J., Landreth G.E. Microglial phagocytosis induced by fibrillar amyloid-β and IgGs are differentially regulated by proinflammatory cytokines. J. Neurosci. 2005, 25:8240-8249.
22. Mitrasinovic O.M., Jr G.M. Murphy, accelerated phagocytosis of amyloid-β by mouse and human microglia overexpressing the macrophage colony-stimulating factor receptor. J. Biol. Chem. 2002, 277:29889-29896.
23. Smith C.J., Zhang Y., Koboldt C.M., et al. Pharmacological analysis of cyclooxygenase-1 in inflammation. Proc. Natl. Acad. Sci. USA 1998, 95:13313-13318.
24. Parashar B., Latha Shankar S., O'Guin K., et al. Inhibition of human neuroblastoma cell growth by CAY10404, a highly selective COX-2 inhibitor. J. Neurooncol. 2005, 71:141-148.
25. Dinarello C.A. The IL-1 family and inflammatory diseases. Clin. Exp. Rheumatol. 2002, 20:S1-S13.
26. Mingam R., De Smedt V., Amedee T., et al. In vitro and in vivo evidence for a role of the P2X7 receptor in the release of IL-1β in the murine brain. Brain Behav. Immun. 2008, 22:234-244.
27. Shie F.S., Breyer R.M., Montine T.J. Microglia lacking E prostanoid receptor subtype 2 have enhanced Aβ phagocytosis yet lack Aβ-activated neurotoxicity. Am. J. Pathol. 2005, 166:1163-1172.
28. Combs C.K., Karlo J.C., Kao S.C., et al. Amyloid-β stimulation of microglia and monocytes results in TNF-α-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. J. Neurosci. 2001, 21:1179-1188.
29. Choi H.B., Ryu J.K., Kim S.U., et al. Modulation of the purinergic P2X7 receptor attenuates lipopolysaccharide-mediated microglial activation and neuronal damage in inflamed brain. J. Neurosci. 2007, 27:4957-4968.